18-12-8　ⓔ文献

  1. Darnell RB, Posner JB: Paraneoplastic syndromes involving the nervous system. New Eng J Med, 2003; 349: 1543–1554.

  2. Pittock SJ, Kryzer TJ, et al: Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Annal Neurol, 2004; 56: 715–719.

  3. Leypoldt F, Wandinger KP: Paraneoplastic neurological syndromes. Clin Exp Immunol, 2014; 175: 336–348.

  4. Hoftberger R, Rosenfeld MR, et al: Update on neurological paraneoplastic syndromes. Curr Opin Oncol, 2015; 27: 489–495.

  5. Rosenfeld MR, Dalmau J: Paraneoplastic neurologic syndromes. Neurol Clin, 2018; 36: 675–685.

  6. Zhang L, Qian W, et al: Imbalance in circulating T lymphocyte subsets contributes to Hu antibody–associated paraneoplastic neurological syndromes. Cell Immunol, 2014; 290: 245–250.

  7. Planaguma J, Leypoldt F, et al: Human N–methyl D–aspartate receptor antibodies alter memory and behaviour in mice. Brain : J Neurol, 2015; 138: 94–109.

  8. Petit-Pedrol M, Armangue T, et al: Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol, 2014; 13: 276–286.

  9. Titulaer MJ, Soffietti R, et al: Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Euro J Neurol, 2011; 18: 19-e13.

  10. Dalmau J, Graus F, et al: Anti–Hu–associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine, 1992; 71: 59–72.

  11. Antoine JC, Honnorat J, et al: Paraneoplastic anti–CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy. Ann Neurol, 2001; 49: 214–221.

  12. Dalmau J, Tuzun E, et al: Paraneoplastic anti–N–methyl–D–aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol, 2007; 61: 25–36.

  13. Dalmau J, Gleichman AJ, et al: Anti–NMDA–receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol, 2008; 7: 1091–1098.

  14. Hoftberger R, van Sonderen A, et al: Encephalitis and AMPA receptor antibodies: Novel findings in a case series of 22 patients. Neurology, 2015; 84: 2403–2412.

  15. Lancaster E, Lai M, et al: Antibodies to the GABA (B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol, 2010; 9: 67–76.

  16. Lai M, Huijbers MG, et al: Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol, 2010; 9: 776–785.

  17. Lancaster E, Huijbers MG, et al: Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol, 2011; 69: 303–311.

  18. Peterson K, Rosenblum MK, et al: Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti–Yo antibody–positive patients. Neurology, 1992; 42: 1931–1937.

  19. Greene M, Lai Y, et al: Antibodies to Delta/notch–like epidermal growth factor–related receptor in patients with anti–Tr, paraneoplastic cerebellar degeneration, and Hodgkin lymphoma. JAMA Neurol, 2014; 71: 1003–1008.

  20. Graus F, Keime–Guibert F, et al: Anti–Hu–associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain : J Neurol, 2001; 124: 1138–1148.